Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 30, 2023

SELL
$211.82 - $248.24 $139,377 - $163,341
-658 Reduced 6.55%
9,393 $2.12 Million
Q2 2023

Jul 17, 2023

SELL
$205.19 - $232.99 $1.2 Million - $1.36 Million
-5,841 Reduced 36.75%
10,051 $2.22 Million
Q1 2023

May 02, 2023

SELL
$212.99 - $276.17 $115,014 - $149,131
-540 Reduced 3.29%
15,892 $3.52 Million
Q4 2022

Jan 26, 2023

BUY
$205.95 - $280.43 $1.67 Million - $2.28 Million
8,120 Added 97.69%
16,432 $4.55 Million
Q3 2022

Oct 31, 2022

BUY
$203.3 - $244.17 $665,197 - $798,924
3,272 Added 64.92%
8,312 $1.73 Million
Q2 2022

Jul 19, 2022

BUY
$174.81 - $241.14 $881,042 - $1.22 Million
5,040 New
5,040 $1.19 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Harel Insurance Investments & Financial Services Ltd. Portfolio

Follow Harel Insurance Investments & Financial Services Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.